Abstract
Rapidly growing members of the genus Mycobacterium were most often associated with chronic (2 to 72 months), nonhealing skin lesions of dogs and cats. Mycobacterium fortuitum (M. fortuitum) was the most commonly isolated mycobacterium obtained from these lesions, although M. chelonae-abscessus and M. flavescens were occasionally encountered. Isolates were tested in vitro to various antimicrobial agents and found to be susceptible to amikacin (100% of the isolates), cefoxitin (93.8%), ciprofloxacin (75%), clarithromycin (71.4%), doxycycline (28.6%), erythromycin (6.2%), gentamicin (68.8%), kanamycin (75%), minocycline (81.3%), streptomycin (14.3%), tobramycin (43.8%), trimethoprim/sulfonamides (57.1%), and vancomycin (15.4%).
MeSH terms
-
Amikacin / pharmacology
-
Animals
-
Anti-Bacterial Agents / pharmacology*
-
Cat Diseases / microbiology*
-
Cats
-
Cefoxitin / pharmacology
-
Ciprofloxacin / pharmacology
-
Clarithromycin / pharmacology
-
Dog Diseases / microbiology*
-
Dogs
-
Doxycycline / pharmacology
-
Erythromycin / pharmacology
-
Female
-
Male
-
Microbial Sensitivity Tests
-
Mycobacterium / classification
-
Mycobacterium / drug effects*
-
Mycobacterium / isolation & purification
-
Mycobacterium Infections / microbiology
-
Mycobacterium Infections / veterinary*
-
Skin Diseases, Bacterial / microbiology
-
Skin Diseases, Bacterial / veterinary*
-
Tobramycin / pharmacology
-
Trimethoprim / pharmacology
-
Vancomycin / pharmacology
Substances
-
Anti-Bacterial Agents
-
Ciprofloxacin
-
Erythromycin
-
Cefoxitin
-
Vancomycin
-
Amikacin
-
Trimethoprim
-
Clarithromycin
-
Doxycycline
-
Tobramycin